Inventor
HAIGHT ANTHONY R
US36 patents
⚠️ This page may combine multiple inventors who share the name “HAIGHT ANTHONY R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
21 patentsUS6437106B1Aug 20, 2002
Process for preparing 6-o-substituted erythromycin derivatives
ABBOTT LAB161 citations96
US6150530ANov 21, 2000
Retroviral protease inhibiting compounds
ABBOTT LAB35 citations96
US5491253AFeb 13, 1996
Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
ABBOTT LAB25 citations94
US5580984ADec 3, 1996
Retroviral protease inhibiting compounds
ABBOTT LAB16 citations86
US6017928AJan 25, 2000
Retroviral protease inhibiting compounds
ABBOTT LAB15 citations82
US5654466AAug 5, 1997
Process for the preparation of a disubstituted 2,5-diamino-3-hydroxyhexane
ABBOTT LAB9 citations82
US5616776AApr 1, 1997
Process for the preparation of a substituted 2.5-diamono-3-hydroxy-hexane
ABBOTT LAB14 citations81
US5508409AApr 16, 1996
Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane
ABBOTT LAB3 citations73
US5284954AFeb 8, 1994
Process for the preparation of tetrazoles
ABBOTT LAB16 citations71
US5565604AOct 15, 1996
Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
ABBOTT LAB2 citations62
US5543551AAug 6, 1996
Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane
ABBOTT LAB2 citations61
US5932766AAug 3, 1999
Process for the preparation of substituted keto-enamines
ABBOTT LAB2 citations60
US5672706ASep 30, 1997
Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
ABBOTT LAB4 citations56
US6667404B2Dec 23, 2003
Retroviral protease inhibiting compounds
ABBOTT LAB0 citations52
US5625092AApr 29, 1997
Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane
ABBOTT LAB0 citations52
US5543549AAug 6, 1996
Process for the preparation of a substituted 2,5-Diamino-3-Hydroxyhexane
ABBOTT LAB0 citations52
US5569777AOct 29, 1996
Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
ABBOTT LAB0 citations51
US5543552AAug 6, 1996
Process for the prepartation of a substituted 2,5-diamino-3-hydroxyhexane
ABBOTT LAB0 citations51
US5541328AJul 30, 1996
Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
ABBOTT LAB0 citations51
US6124474ASep 26, 2000
Synthesis of chiral 2-azetidinemethanol compounds
ABBOTT LAB1 citations48
US7071314B2Jul 4, 2006
Arylation method for the functionalization of O-allyl erythromycin derivatives
ABBOTT LAB0 citations34
ABBVIE INC
7 patentsUS9381508B2Jul 5, 2016
Phosphine ligands for catalytic reactions
ABBVIE INC3 citations72
US9266913B2Feb 23, 2016
Phosphine ligands for catalytic reactions
ABBVIE INC3 citations72
US9434698B2Sep 6, 2016
Process for preparing antiviral compounds
ABBVIE INC1 citations62
US9200021B2Dec 1, 2015
Phosphine ligands for catalytic reactions
ABBVIE INC3 citations62
US9732045B2Aug 15, 2017
Process for preparing antiviral compounds
ABBVIE INC0 citations51
US9669399B2Jun 6, 2017
Phosphine ligands for catalytic reactions
ABBVIE INC0 citations51
US8377913B2Feb 19, 2013
Vitamin D receptor activators and methods of making
ABBVIE INC1 citations47
SHEKHAR SHASHANK
4 patentsUS8975443B2Mar 10, 2015
Phosphine ligands for catalytic reactions
SHEKHAR SHASHANK4 citations82
US8841487B2Sep 23, 2014
Phosphine ligands for catalytic reactions
SHEKHAR SHASHANK8 citations82
US8895737B2Nov 25, 2014
Process for preparing antiviral compounds
SHEKHAR SHASHANK5 citations71
US9255074B2Feb 9, 2016
Process for preparing antiviral compounds
SHEKHAR SHASHANK0 citations50